Highlights and Quick Summary
- Change in Cash for the quarter ending September 30, 2022 was $13.1 Million (a -86.65% decrease compared to previous quarter)
- Year-over-year quarterly Change in Cash decreased by -93.84%
- Annual Change in Cash for 2021 was $37.7 Million (a -782.96% decrease from previous year)
- Annual Change in Cash for 2020 was $-5.52 Million (a -92.34% decrease from previous year)
- Annual Change in Cash for 2019 was $-72 Million (a -120.95% decrease from previous year)
- Twelve month Change in Cash ending September 30, 2022 was $303 Million (a 230.76% increase compared to previous quarter)
- Twelve month trailing Change in Cash increased by 703.23% year-over-year
Trailing Change in Cash for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $303 Million | $91.5 Million | $-99.6 Million | $37.7 Million |
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Change in Cash of BridgeBio Pharma, Inc.
Most recent Change in Cashof BBIO including historical data for past 10 years.Interactive Chart of Change in Cash of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Change in Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $13.14 | $98.45 | $-22.17 | – |
| 2021 | $213.29 | $-198.05 | $-92.65 | $115.1 | $37.69 |
| 2020 | $-8.71 | $-173.95 | $-216.13 | $393.28 | $-5.52 |
| 2019 | $-50.2 | $120.17 | $-78.8 | $-63.22 | $-72.05 |
| 2018 | – | – | $224.16 | $119.71 | $343.87 |
| 2017 | $72.03 | – | – | – | $72.03 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology